Literature DB >> 2412849

The effect of the calcium channel agonist, Bay K-8644 on human vascular smooth muscle.

V Gopalakrishnan, L E Park, C R Triggle.   

Abstract

Bay K-8644, a calcium channel activator, caused a dose-dependent (ED50 = 12.8 nM) elevation of tone in the human umbilical artery. The response to Bay K-8644 was dependent upon extracellular calcium (Ca2+), competitively antagonized by the channel antagonist, nifedipine, and, in addition, the sensitivity to Bay K-8644 was increased by, but not dependent upon, elevating extracellular potassium. Bay K-8644 competitively displaced, IC50 = 1.8 nM, specific [3H]nitrendipine binding to a microsome fraction derived from the umbilical artery, suggesting that the Ca2+ channel activator and the structurally related dihydropyridine antagonists bind to a single site to affect Ca2+ channel function in human vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412849     DOI: 10.1016/0014-2999(85)90095-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Effects of Bay K 8644 and nifedipine on femoral arteries of spontaneously hypertensive rats.

Authors:  K Aoki; M Asano
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

2.  Bay K 8644-induced changes in the ECG pattern of the rat and their inhibition by antianginal drugs.

Authors:  S Abraham; G Amitai; N Oz; B A Weissman
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

3.  Bay K 8644 induced necrosis in murine skeletal muscle in vitro: myofibre breakdown precedes significant alterations of intracellular [Ca] or pH.

Authors:  J D Howl; S J Publicover
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Differential effects of phosphoramidon on contractile responses to angiotensin II in rat blood vessels.

Authors:  L Chen; J R McNeill; T W Wilson; V Gopalakrishnan
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

5.  Evidence for the presence of regional differences in the calcium antagonist receptors in lower urinary tract smooth muscle.

Authors:  J Latifpour; M Yoshida; R M Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

6.  Early and late contraction induced by ouabain in human umbilical arteries.

Authors:  K Sato; K Aoki
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

7.  Effects of calcium channel blockade in canine saphenous veins after storage at -190 degrees C.

Authors:  A B Ebeigbe; E Müller-Schweinitzer; A Vogel
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

8.  Potentiation by acetylcholine of the effects of a calcium channel activator, Bay k 8644, on dog atria in situ.

Authors:  J Lang; Q T Chah; J P Lançon; P Charve; J F Aupetit; J Loufoua-Moundanga; G Faucon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

9.  Sustained Contraction in Vascular Smooth Muscle by Activation of L-type Ca2+ Channels Does Not Involve Ca2+ Sensitization or Caldesmon.

Authors:  Hillevi K Ets; Chun Y Seow; Robert S Moreland
Journal:  Front Pharmacol       Date:  2016-12-26       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.